Guru Ownership Trend
Guru Analysis for Puma Biotechnology, Inc. (PBYI)
Puma Biotechnology, Inc. (PBYI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $22.27 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $455,595.39 net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 20.0%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 8.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Puma Biotechnology, Inc. (PBYI)
Major holders include Renaissance Technologies (RenTech) ($12.41 M), Cliff Asness ($5.11 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 2.74 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $455,595.39, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited PBYI. The total reported sell value was $1.31 M.
Yes, 0 managers opened new positions in PBYI, and 1 increased their existing holdings. The total reported buy value was $853,633.6.